Davide Firinu Orietta Massidda Maria Maddalena Lorrai Loredana Serusi Monica Peralta Maria Pina Barca Paolo Serra Paolo Emilio Manconi
10.1155/2011/283239
Clin Dev Immunol
2011;2011:283239.
CC BY
https://pubmed.ncbi.nlm.nih.gov/21197459/
Candidiasis, Chronic Mucocutaneous / drug therapy Candidiasis, Chronic Mucocutaneous / immunology Triazoles / administration & dosage Triazoles / therapeutic use
Candidiasis, Chronic Mucocutaneous / drug therapy Candidiasis, Chronic Mucocutaneous / immunology Triazoles / administration & dosage Triazoles / therapeutic use Case Reports Administration, Oral Adult Antifungal Agents / therapeutic use Candida albicans / pathogenicity Drug Resistance, Fungal Female Humans Treatment Outcome Antifungal Agents Triazoles posaconazole
PMC3003968
21197459
Successful treatment of chronic mucocutaneous candidiasis caused by azole-resistant Candida albicans with posaconazole
2011